Rosmantuzumab
Appearance
Monoclonal antibody | |
---|---|
Type | ? |
Source | Humanized (from mouse) |
Target | root plate-specific spondin 3 |
Clinical data | |
Other names | OMP-131R10 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C6456H9954N1714O2048S46 |
Molar mass | 145.8 g/mol g·mol−1 |
Rosmantuzumab (OMP-131R10) (INN[1]) is a humanized monoclonal antibody designed for the treatment of cancer.
This drug was developed by OncoMed Pharmaceuticals.[2]